David Gower
GlaxoSmithKline (United Kingdom)(GB)Molecular Discovery (United Kingdom)(GB)
Publications by Year
Research Areas
Influenza Virus Research Studies, Respiratory viral infections research, Pneumonia and Respiratory Infections, Monoclonal and Polyclonal Antibodies Research, Aquaculture disease management and microbiota
Most-Cited Works
- → A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infectionin vitro andin vivo(1999)131 cited
- → Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza(2005)88 cited
- → Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen(2004)80 cited
- → Characterization of 2 Influenza A(H3N2) Clinical Isolates with Reduced Susceptibility to Neuraminidase Inhibitors Due to Mutations in the Hemagglutinin Gene(2002)58 cited
- → Genomic and phenotypic divergence among three serotypes of aquatic birnaviruses (infectious pancreatic necrosis virus)(1981)57 cited
- → Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase(2004)57 cited
- → Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract(1999)21 cited
- → Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies(2020)13 cited
- → Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV(1995)12 cited
- → SP-A and SP-D modulate the infectivity of RSV(2000)